Avery Dennison partnered with Schreiner MediPharm and PragmatIC Semiconductor to leverage NFC technology

Smart pharma packaging to revolutionize patient safety and experience

Together with Schreiner MediPharm and PragmatIC Semiconductor, Avery Dennison is leveraging NFC technology to extend smart packaging to the unit-level for everyday pharma in order to significantly improve patient safety and experiences.

State-of-the-art NFC technology has a lot to offer in smart packaging applications, it can be used for tamper evidence, secure authentication, end-to-end traceability, and easy re-ordering. In the case of pharmaceutical products it can also connect the patient to, not only easy-to-read instructions, but also video/audio guides, help lines, social media support groups and even to their doctor or clinician. Previously, this functionality was restricted to high-value (or high-risk) products due to the cost of traditional NFC inlays and their Integrated Circuits (ICs or “chips”). Now, thanks to the joint effort of Schreiner MediPharm, PragmatIC, and Avery Dennison, these options can be embedded in cost-sensitive, everyday healthcare and pharmaceutical products.

New NFC smart packaging solutions leverage low-cost, flexible and robust ICs

At the core of these new cost-effective smart solutions are Avery Dennison’s NFC inlays, which include NFC ICs from the ConnectIC® range of products manufactured by PragmatIC, a UK-based world leader in ultra-low-cost electronics. As these flexible ICs (“FlexICs”) are thinner than a human hair and robust, they are suitable for small diameter objects and provide the ideal solution for adding a unique identity to cost-sensitive products, for example small syringes, or vials.

Avery Dennison’s inlays with ConnectIC chips have been adopted by Schreiner MediPharm to extend its portfolio. The supplier, based near Munich, Germany, develops and produces innovative specialty labels and self-adhesive marking solutions with value-added benefits for the pharmaceutical and medical device industry.

“For Schreiner MediPharm, solving customer- and application-specific problems is of particular importance. The partnership with Avery Dennison and PragmatIC enables unmet needs to be served in order to support users and to avoid medication errors for a much wider range of products. Thus, we can contribute to enhanced product safety and support patient centricity at a much larger scale”, said Stefan Wiedemann, Senior Director Strategic Marketing and Business Development at Schreiner MediPharm.

“This partnership illustrates how our ground-breaking ConnectIC product line is set to accelerate the deployment of RFID-based digital solutions in the healthcare sector,” commented Scott White, CEO of PragmatIC. “We are really pleased to see adoption of our technology by leading global suppliers like Schreiner MediPharm and Avery Dennison and look forward to working closely with both of them to improve patient outcomes around the world.”

Enhancing patient safety and experiences

We have always believed that integrating RFID into pharmaceutical products helps improve patient safety by enabling more accurate tracking and authentication of medication through the entire supply chain, with the goal of reducing error rates to nearly zero. With our new low-cost inlays based on ConnectIC FlexICs and our partnership with PragmatIC and Schreiner MediPharm, we help to enhance patient safety and experiences through novel smart packaging applications

 

said Francisco Melo, Vice President and General Manager, Avery Dennison Intelligent Labels.

Avery Dennison’s special low-cost NFC inlays and Schreiner MediPharm’s labeling solution are expected to be available in the first quarter of 2021.

Read the full press release and find out more about Avery Dennison